Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Refractory Uveitic Cystoid Macular Oedema
NCT01564108Phase 2Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- May 2012
- Primary completion
- Jun 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in uveitic cystoid macular edema (UME), sponsored by Moorfields Eye Hospital. Started May 2012; status: completed.
02
Drugs
ranibizumab
03
Conditions
uveitic cystoid macular edema (UME)
Beyond the preview
Go deeper on NCT01564108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01564108.